Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Antibodies directed to HER-3 and uses thereof

Antibodies directed to HER-3 and uses thereof

US Patent 11267900 · Granted Mar 8, 2022

Estimated economic value: $201,888,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Binding molecules for BCMA and CD32025
Binding molecules for BCMA and CD32025
Tandem diabody for CD16A-directed NK-cell engagement2025
Bispecific and tetravalent CD137 and FAP molecules for the treatment of cancer2024
Bispecific EGFR/CD16 antigen-binding protein2024
Human anti-IFN-α antibodies2024
Multivalent FV antibodies2023
Combination of an anti-CD16A antibody with a cytokine2022
Bispecific EGFR/CD16 antigen-binding protein2022
Antibodies directed to the deletion mutants of epidermal growth factor receptor 2022
Anti-CD47 antibodies2022
Genetic engineering of non-human animals for the production of chimeric antibodi2022